Mills KHG - Search Results

1

Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Gu XX, Plotkin SA, Edwards KM, Sette A, Mills KHG, Levy O, Sant AJ, Mo A, Alexander W, Lu KT, Taylor CE. Gu XX, et al. Among authors: mills khg. Clin Vaccine Immunol. 2017 Jul 5;24(7):e00034-17. doi: 10.1128/CVI.00034-17. Print 2017 Jul. Clin Vaccine Immunol. 2017. PMID: 28490424 Free PMC article.

2

Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.

Mills KH. Mills KH. Immunol Lett. 2009 Feb 21;122(2):108-11. doi: 10.1016/j.imlet.2008.11.007. Epub 2008 Dec 25. Immunol Lett. 2009. PMID: 19100777 Review.

3

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

Butt AQ, Mills KH. Butt AQ, et al. Oncogene. 2014 Sep 18;33(38):4623-31. doi: 10.1038/onc.2013.432. Epub 2013 Oct 21. Oncogene. 2014. PMID: 24141774 Review.

4

Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.

Allen AC, Mills KH. Allen AC, et al. Expert Rev Vaccines. 2014 Oct;13(10):1253-64. doi: 10.1586/14760584.2014.936391. Epub 2014 Jul 12. Expert Rev Vaccines. 2014. PMID: 25017925 Free article. Review.

5

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KH. Dunne A, et al. Mucosal Immunol. 2015 May;8(3):607-17. doi: 10.1038/mi.2014.93. Epub 2014 Oct 15. Mucosal Immunol. 2015. PMID: 25315966 Free article.

6

Pertussis: Biology, epidemiology and prevention.

Saadatian-Elahi M, Plotkin S, Mills KHG, Halperin SA, McIntyre PB, Picot V, Louis J, Johnson DR. Saadatian-Elahi M, et al. Among authors: mills khg. Vaccine. 2016 Nov 21;34(48):5819-5826. doi: 10.1016/j.vaccine.2016.10.029. Epub 2016 Oct 22. Vaccine. 2016. PMID: 27780629

7

Immune checkpoints and their inhibition in cancer and infectious diseases.

Dyck L, Mills KHG. Dyck L, et al. Among authors: mills khg. Eur J Immunol. 2017 May;47(5):765-779. doi: 10.1002/eji.201646875. Epub 2017 Apr 24. Eur J Immunol. 2017. PMID: 28393361 Free article. Review.

8

Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.

Misiak A, Leuzzi R, Allen AC, Galletti B, Baudner BC, D'Oro U, O'Hagan DT, Pizza M, Seubert A, Mills KHG. Misiak A, et al. Among authors: mills khg. Vaccine. 2017 Sep 18;35(39):5256-5263. doi: 10.1016/j.vaccine.2017.08.009. Epub 2017 Aug 18. Vaccine. 2017. PMID: 28823618 Free article.

9

CD4 T_RM Cells Following Infection and Immunization: Implications for More Effective Vaccine Design.

Wilk MM, Mills KHG. Wilk MM, et al. Among authors: mills khg. Front Immunol. 2018 Aug 10;9:1860. doi: 10.3389/fimmu.2018.01860. eCollection 2018. Front Immunol. 2018. PMID: 30147701 Free PMC article. Review.

10

Highlights of the 12th International Bordetella Symposium.

Locht C, Carbonetti NH, Cherry JD, Damron FH, Edwards KM, Fernandez R, Harvill ET, Hozbor D, Mills KHG, Rodriguez ME, Mascart F. Locht C, et al. Among authors: mills khg. Clin Infect Dis. 2020 Dec 3;71(9):2521-2526. doi: 10.1093/cid/ciaa651. Clin Infect Dis. 2020. PMID: 32463883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters